Luoyan Ai
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Gut microbiota and health 3
- Chromatin Remodeling and Cancer 2
- Peroxisome Proliferator-Activated Receptors 2
- Oncology 8
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Jie Xu (7 shared papers)Antao Xu (5 shared papers)Jing‐Yuan Fang (6 shared papers)Zhaofei Chen (4 shared papers)Jin Qian (3 shared papers)Lunxi Liang (2 shared papers)Yingxuan Chen (4 shared papers)Yun Qian (3 shared papers)
- Journals
- Nature Communications (2 papers)Gene (1 paper)Scientific Reports (1 paper)Annals of Palliative Medicine (1 paper)Oncogenesis (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Luoyan Ai
21 papers receiving 826 citations
Luoyan Ai's Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 371
- Immunology 220
- Cancer Research 122
- Biological Psychiatry 16
- Molecular Biology 397
Countries citing papers authored by Luoyan Ai
This map shows the geographic impact of Luoyan Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoyan Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoyan Ai more than expected).
Fields of papers citing papers by Luoyan Ai
This network shows the impact of papers produced by Luoyan Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoyan Ai. The network helps show where Luoyan Ai may publish in the future.
Co-authors
The 25 scholars most cited alongside Luoyan Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond Hit paper breakdown → | 2020 | 362 |
| 2 | 2015 | 85 | |
| 3 | 2015 | 74 | |
| 4 | 2017 | 66 | |
| 5 | 2021 | 46 | |
| 6 | 2021 | 42 | |
| 7 | 2021 | 26 | |
| 8 | 2015 | 19 | |
| 9 | 2017 | 19 | |
| 10 | 2014 | 18 | |
| 11 | 2024 | 16 | |
| 12 | 2022 | 14 | |
| 13 | 2018 | 11 | |
| 14 | 2017 | 9 | |
| 15 | 2021 | 8 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2020 | 3 | |
| 20 | 2017 | 2 |
About Luoyan Ai
Luoyan Ai is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Pathology and Forensic Medicine, having authored 23 papers that have together received 837 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers), Gut microbiota and health (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Chromatin Remodeling and Cancer (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Oncology (371 citations), Immunology (220 citations), Cancer Research (122 citations), Biological Psychiatry (16 citations) and Molecular Biology (397 citations). Luoyan Ai has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jie Xu, Antao Xu, Jing‐Yuan Fang, Zhaofei Chen, Jin Qian, Lunxi Liang, Yingxuan Chen, Yun Qian, Huimin Chen and Zhuping Fan. Their work appears in journals such as Nature Communications, Gene, Scientific Reports, Annals of Palliative Medicine and Oncogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.